Here is My Question:
Could Ocrevus help manage my MS and inflammatory arthritis?
Anti-CD20 monoclonal antibody therapies used to treat multiple sclerosis (examples include Rituximab, Ocrevus and Kemsimpta) are effective treatments for inflammatory arthropathies including rheumatoid arthritis (Rituximab is FDA approved ), psoriatic arthritis and ankylosing spondyloarthropathies (small case series only).
Revere (Rip) Kinkel MD
Director of the Multiple Sclerosis Program
Professor of Clinical Neurosciences
University of California San Diego
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.